Phase II trial of gemcitabine (GEM) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) as first line treatment for patients with locally advanced and metastatic exocrine pancreatic cancer Academic Article 2001 uri icon

authors

  • Maurel J.
  • Aranda E.
  • Llanos M.
  • Sastre J.
  • Dorta J.
  • CARRATO MENA, ALFREDO
  • García-López J.L.
  • León A.
  • Bretón J.J.
  • Fernández-Martos C.
  • Florián J.
  • Sánchez-Rovira P.
  • Casinello J.
  • Galán M.C.

publication date

  • 2001